These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Applications of calcium channel blockers in psychiatry: pharmacokinetic and pharmacodynamic aspects of treatment of bipolar disorder. Dubovsky SL Expert Opin Drug Metab Toxicol; 2019 Jan; 15(1):35-47. PubMed ID: 30558453 [No Abstract] [Full Text] [Related]
3. [Calcium antagonists and lithium in preventive treatment of manic-depressive disorder]. Sarfati Y; Spadone C; Vanelle JM; Lôo H Encephale; 1996; 22(2):149-53. PubMed ID: 8706625 [TBL] [Abstract][Full Text] [Related]
4. Weight gain and metabolic effects of mood stabilizers and antipsychotics in pediatric bipolar disorder: a systematic review and pooled analysis of short-term trials. Correll CU J Am Acad Child Adolesc Psychiatry; 2007 Jun; 46(6):687-700. PubMed ID: 17513981 [TBL] [Abstract][Full Text] [Related]
5. Mood stabilizers in pregnancy and child developmental outcomes: A systematic review. Haskey C; Galbally M Aust N Z J Psychiatry; 2017 Nov; 51(11):1087-1097. PubMed ID: 28825316 [TBL] [Abstract][Full Text] [Related]
6. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review]. Munch G; Godart N Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720 [TBL] [Abstract][Full Text] [Related]
7. Mood stabilizers and atypical antipsychotics: bimodal treatments for bipolar disorder. Ketter TA; Nasrallah HA; Fagiolini A Psychopharmacol Bull; 2006; 39(1):120-46. PubMed ID: 17065977 [TBL] [Abstract][Full Text] [Related]
11. Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge. Rybakowski JK CNS Drugs; 2013 Mar; 27(3):165-73. PubMed ID: 23378337 [TBL] [Abstract][Full Text] [Related]
12. Pharmacotherapy of mood disorders and psychosis in pre- and post-natal women. Smith B; Dubovsky SL Expert Opin Pharmacother; 2017 Nov; 18(16):1703-1719. PubMed ID: 29019422 [TBL] [Abstract][Full Text] [Related]
13. [Pharmacotherapy in bipolar disorders during childhood and adolescence]. Vloet JA; Hagenah UF Z Kinder Jugendpsychiatr Psychother; 2009 Jan; 37(1):27-49, quiz 49-50. PubMed ID: 19105162 [TBL] [Abstract][Full Text] [Related]
14. Rational polypharmacy in the bipolar affective disorders. Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735 [TBL] [Abstract][Full Text] [Related]
15. Psychotropic use and risk of stroke among patients with bipolar disorders: 10-year nationwide population based study. Wu CS; Wu KY; Lo YR; Huang YW; Tsai YT; Li Y; Tsai HJ J Affect Disord; 2018 Jan; 226():77-84. PubMed ID: 28964996 [TBL] [Abstract][Full Text] [Related]
16. Understanding the molecular mechanisms underlying mood stabilizer treatments in bipolar disorder: Potential involvement of epigenetics. Pisanu C; Papadima EM; Del Zompo M; Squassina A Neurosci Lett; 2018 Mar; 669():24-31. PubMed ID: 27343410 [TBL] [Abstract][Full Text] [Related]
17. Drug interactions of lithium and other antimanic/mood-stabilizing medications. Dunner DL J Clin Psychiatry; 2003; 64 Suppl 5():38-43. PubMed ID: 12720483 [TBL] [Abstract][Full Text] [Related]
18. Management of antipsychotic and mood stabilizer medication in pregnancy: recommendations for antenatal care. Galbally M; Snellen M; Walker S; Permezel M Aust N Z J Psychiatry; 2010 Feb; 44(2):99-108. PubMed ID: 20113298 [TBL] [Abstract][Full Text] [Related]
19. Mood stabilizers for patients with bipolar disorder: the state of the art. Altamura AC; Lietti L; Dobrea C; Benatti B; Arici C; Dell'Osso B Expert Rev Neurother; 2011 Jan; 11(1):85-99. PubMed ID: 21158558 [TBL] [Abstract][Full Text] [Related]
20. Introduction: the use of mood stabilizers in the treatment of psychiatric disorders. Bowden CL J Clin Psychiatry; 1999; 60 Suppl 5():3-4. PubMed ID: 10192401 [No Abstract] [Full Text] [Related] [Next] [New Search]